Preoperative investigation guidelines

Preoperative Investigations Guidelines 

Preoperative investigations should not be ordered as a routine battery of tests for every patient. The decision should be based on the patient’s clinical condition, comorbidities, medications, age, and the type and extent of surgery.

Two commonly referenced guidelines are:

  • Indian Society of Anaesthesiologists (ISA) Practice Guidelines for Preoperative Investigations — Indian Journal of Anaesthesia (IJA), 2022
  • NICE Guideline NG45: Routine Preoperative Tests for Elective Surgery, 2016

SURGERY CLASSIFICATION 

Surgery is commonly classified according to its magnitude and expected physiological stress as:

Minor → Intermediate → Major

This classification helps determine the extent of preoperative assessment and investigations. It should be considered alongside ASA physical status, patient comorbidities, and urgency of surgery.

Category

Typical characteristics

Examples

Minor surgery

Limited tissue trauma, minimal blood loss, short duration, little physiological disturbance

Cataract surgery, superficial skin procedures, minor breast procedures, diagnostic endoscopy

Intermediate surgery

Moderate tissue trauma, moderate physiological stress and/or blood loss

Laparoscopic cholecystectomy, TURP, hysterectomy, joint arthroscopy, hernia repair

Major surgery

Extensive tissue trauma, significant blood loss/fluid shifts, prolonged duration or major physiological stress

Major abdominal surgery, major vascular surgery, major orthopaedic surgery, oesophagectomy, major thoracic surgery

NICE GUIDELINE 

NICE recommends a selective, risk-based approach to preoperative investigations. The need for testing is determined mainly by the ASA physical status and grade of surgery (minor, intermediate or major), along with the patient’s history and clinical findings. Routine tests are avoided when they are unlikely to influence perioperative management. For example, CBC and renal function are recommended mainly with increasing ASA status and surgical severity, while LFT, coagulation tests and CXR are generally performed only when clinically indicated.


Investigation

Minor surgery

Intermediate surgery

Major surgery

CBC

Not routine

ASA III–IV

All patients

Renal function / Creatinine

Not routine*

ASA III–IV

 ASA II–IV

ECG

Not routine

ASA III–IV

 ASA II–IV

Coagulation profile

Clinical indication

Clinical indication

 Clinical indication

LFT

Clinical indication

Clinical indication

Clinical indication

CXR

Not routine

Not routine

 Not routine

Urinalysis

Not routine

Not routine

Not routine

Pregnancy test

If possibility of pregnancy + result may affect management

Same

 Same

Sickle cell test

Not routine

Not routine

 Not routine

* Renal function may be considered in selected patients at risk of perioperative AKI, including ASA III–IV undergoing minor surgery and ASA II undergoing intermediate surgery.


IJA GUIDELINE 

The IJA/ISA guideline promotes a judicious, individualised approach to preoperative investigations rather than routine testing of every patient. Investigations should be guided by the type of surgery, ASA status, physiological condition, comorbidities, medications and clinical findings, with tests ordered when they are likely to influence perioperative management. It is specifically designed for ASA I–II patients undergoing elective surgery.


Investigation

Minor surgery

Intermediate surgery

Major surgery

CBC

 Suggested

 Suggested

 Suggested

Serum creatinine / RFT

 Not suggested

Suggested

Suggested

Serum Na⁺ / K⁺

 Not suggested routinely

 Not suggested routinely

Not suggested routinely

LFT

 Not suggested

Not suggested

Suggested

Coagulation profile (PT/INR, aPTT)

 Not suggested routinely

Not suggested routinely

Not suggested routinely

Blood glucose – non-diabetic

 Not suggested routinely

 Not suggested routinely

 Not suggested routinely

12-lead ECG

≥45 yr*

≥45 yr*

 All patients

CXR

 Not suggested

≥50 yr†

≥50 yr†

* ECG age criterion applies to non-cardiac patients undergoing minor/intermediate surgery.
† CXR age criterion applies to patients ≥50 years undergoing intermediate/major surgery. 


Complete Blood Count (CBC)

CBC provides information about oxygen-carrying capacity, platelet count and the presence of leukocytosis or other haematological abnormalities.

Parameter

Important points

Haemoglobin

Normal range in the reference: 13.5–17.5 g/dL in men and 12–15.5 g/dL in women.

Haematocrit

Hct <28% is associated with increased postoperative ischaemia and major adverse cardiac events in high-risk patients according to the reference.

Platelets

Normal: 150,000–450,000/µL.

WBC

Leukocytosis may indicate infection/inflammation. Pregnancy may produce physiological leukocytosis, with values reported up to 21,000/µL at term.

Indications

CBC should be considered particularly for:

  • Major surgery with significant blood-loss potential
  • Suspected or known anaemia
  • Haematological disease
  • Malignancy
  • Geriatric patients with suspected baseline anaemia
  • Selected paediatric patients
  • Situations where platelet count may influence the safety of regional/neuraxial anaesthesia


Anaesthetic relevance

CBC helps with:

Anaemia assessment → oxygen delivery assessment → transfusion planning

Platelet assessment → bleeding risk → suitability for neuraxial/regional techniques

The reference gives 100,000/µL as the usual platelet threshold below which regional blocks are avoided, while selected patients with low-grade HELLP may be considered at ≥70,000/µL.


2. Kidney Function Tests (KFT)

KFTs assess baseline renal function and help identify patients at increased risk of preoperative acute kidney injury.

Important parameters

Parameter

Reference values / significance

Creatinine

0.8–1.3 mg/dL in men; 0.6–1.0 mg/dL in women

BUN

10–20 mg/dL

Creatinine clearance / GFR

Useful for assessing renal reserve, particularly in older patients

Indications

Consider KFTs in:

  • Known renal insufficiency
  • Diabetes mellitus
  • Hypertension
  • Cardiovascular disease
  • Geriatric patients
  • Patients at risk of AKI
  • Patients receiving potentially nephrotoxic medications
  • Major surgery where significant fluid shifts are anticipated

Why potassium matters ???


Hypokalaemia

Can predispose to:

  • Arrhythmias
  • Muscle weakness
  • Increased sensitivity to some drugs

Hyperkalaemia

Can cause:

  • Conduction abnormalities
  • Arrhythmias
  • Potential cardiac arrest

Therefore a significant electrolyte abnormality may require correction before elective surgery, depending on severity and clinical context.


Important considerations

Renal function may be overestimated in elderly patients, because loss of muscle mass can mask a reduction in GFR despite a relatively normal serum creatinine.

The reference identifies:

  • Creatinine >1.2 mg/dL → increased AKI risk
  • Creatinine >2.0 mg/dL → significant cardiac risk factor
  • BUN:Creatinine >15:1 → suggests prerenal dehydration/volume depletion

Pregnancy

Pregnancy is associated with increased renal blood flow and GFR. Therefore, serum creatinine is normally lower, approximately 0.5–0.6 mg/dL. A creatinine >1.0 mg/dL in pregnancy warrants evaluation.

Anaesthetic relevance

Renal assessment influences:

  • Fluid management
  • Electrolyte correction
  • Drug dosing
  • Choice and duration of neuromuscular blockers
  • Risk assessment for postoperative AKI

3. Liver Function Tests (LFT)

Routine LFTs are not indicated in everyone.

LFTs are useful for assessing hepatocellular injury, hepatic synthetic function and nutritional status.

Consider LFTs in:

  • Cirrhosis
  • Active hepatitis
  • Known liver disease
  • Malnutrition
  • Jaundice
  • Passive hepatic congestion associated with severe right heart failure
  • HELLP syndrome
  • Planned major hepatic resection

Parameters may include:

  • Bilirubin
  • AST/ALT
  • ALP
  • Albumin

LFTs do not directly equal hepatic functional reserve.

For significant liver disease, also consider:

  • INR
  • Albumin
  • Platelets
  • Bilirubin
  • Clinical portal hypertension
  • Ascites
  • Encephalopathy
  • Renal function

Albumin

The reference lists normal albumin as 3.5–5.5 g/dL.

Albumin has a relatively long half-life of approximately 2–3 weeks. Therefore, it may remain normal during acute liver injury.

Albumin <2.5 g/dL suggests chronic liver disease, severe malnutrition or protein-losing states. Hypoalbuminaemia can increase the free fraction of highly protein-bound drugs.

Pseudocholinesterase

Pseudocholinesterase is synthesized in the liver and is responsible for hydrolysis of:

  • Succinylcholine
  • Ester local anaesthetics

Its level decreases during pregnancy and falls significantly in HELLP syndrome.


Anaesthetic relevance

Liver dysfunction may result in:

Altered drug metabolism + altered protein binding + coagulation abnormalities + prolonged drug action


Important parameters

Parameter

Significance

ALT / AST

Markers of hepatocellular injury rather than direct measures of liver function

Albumin

Reflects chronic hepatic synthetic/nutritional status

Bilirubin

Reflects hepatic excretory function and bile handling; elevation may indicate hepatocellular dysfunction, cholestasis, or biliary obstruction

Pseudocholinesterase

Relevant to metabolism of succinylcholine and ester local anaesthetics

4. Coagulation Profile

The coagulation profile evaluates secondary haemostasis and is particularly relevant when bleeding risk or neuraxial anaesthesia is a concern.

Important parameters


Test

Reference value

What it assesses

PT

11–14 sec

Extrinsic/common pathway

INR

~1.0

Standardized assessment of PT

aPTT

25–35 sec

Intrinsic/common pathway

Fibrinogen

200–400 mg/dL

Fibrin formation/clot strength

Indications

Consider coagulation testing in:

  • Patients taking long-term anticoagulants
  • Known or suspected liver disease
  • Significant bleeding history
  • Severe preeclampsia
  • HELLP syndrome
  • Patients in whom regional/neuraxial anaesthesia is being considered

PT / INR

PT is particularly sensitive to abnormalities in hepatic synthetic function because Factor VII has a short half-life.

The reference identifies PT prolongation >3 seconds / INR >1.5 as suggestive of severe hepatic synthetic dysfunction.

Fibrinogen

Normal fibrinogen is approximately 200–400 mg/dL.

In pregnancy, fibrinogen physiologically increases to approximately 400–500 mg/dL. A significant fall, particularly around delivery, can be an early warning sign of severe postpartum haemorrhage.

Anaesthetic relevance

Coagulation assessment helps determine:

Bleeding risk → need for correction/blood products → safety of neuraxial anaesthesia


5. 12-Lead ECG

A 12-lead ECG provides information regarding:

  • Heart rate
  • Rhythm
  • Conduction
  • Ischaemic changes
  • Evidence of LV hypertrophy

Indications

Consider ECG in patients with:

  • Known coronary artery disease
  • Previous myocardial infarction
  • Heart failure
  • Hypertension
  • Renal impairment
  • Relevant cardiovascular symptoms
  • Patients receiving drugs such as digoxin or diuretics
  • Selected older/high-risk patients

Anaesthetic relevance

ECG may identify:

Silent ischaemia + Arrhythmias + Conduction abnormalities + LVH

These findings may alter the need for further cardiovascular evaluation, monitoring and perioperative planning.


6. Pulmonary Investigations

Spirometry / Pulmonary Function Tests

Important parameters include:

  • FEV₁
  • FVC
  • DLCO

Indications

Consider in:

  • Known COPD
  • Known asthma when baseline assessment is useful
  • Major thoracic surgery
  • Planned lung resection

For lung resection, the reference highlights predicted postoperative FEV₁ and DLCO >40% as an important threshold.

Spirometry and chest radiography should not be used routinely in asymptomatic patients simply to predict postoperative pulmonary complications.


7. Chest X-ray

Chest radiography is not a routine investigation for every patient.

It may be considered when there is:

  • Significant respiratory disease
  • Significant cardiac disease
  • Relevant respiratory symptoms
  • Suspected pulmonary pathology
  • A specific surgical indication

Potential findings include:

  • Hyperinflation
  • Cardiomegaly
  • Pulmonary pathology

8. Arterial Blood Gas (ABG)

ABG provides information about:

  • pH
  • PaO₂
  • PaCO₂
  • HCO₃⁻

Indications

Consider ABG in:

  • Severe asthma/COPD undergoing major thoracic or abdominal surgery
  • Significant respiratory disease with concern regarding gas exchange
  • Kidney failure with tachypnoea
  • Suspected significant acid-base disturbance


Anaesthetic relevance

ABG establishes a baseline for:

Oxygenation + Ventilation + Acid-base status


9. Echocardiography

This is not a routine preoperative test.

Consider when there is clinical suspicion of significant structural/functional heart disease.

Examples:

  • Suspected heart failure

Symptoms:

  • Dyspnoea
  • Orthopnoea
  • PND
  • Peripheral oedema

– Suspected significant valvular disease

For example:

  • Severe AS
  • Significant MR

– Unexplained dyspnoea

Known cardiac disease with a clinically important change


Why does echo matter to the anaesthesiologist?

It gives information about:

  • LV systolic function
  • Diastolic function
  • Valve pathology
  • Chamber size
  • Pulmonary pressures
  • RV function

This can fundamentally change:

Anaesthetic technique + monitoring + haemodynamic goals.


Investigation

When is it indicated?

What are we looking for?

Anaesthetic relevance

CBC / Hemogram

Suspected or known anaemia, bleeding history, haematological disease, malignancy, major surgery or significant expected blood loss

Haemoglobin, platelet count, leukocyte abnormalities

Anaemia affects oxygen delivery; thrombocytopenia may increase bleeding risk and influence suitability for neuraxial procedures

KFT + Electrolytes

Renal disease, diabetes, hypertension, cardiovascular disease, suspected renal impairment, elderly patients, major surgery or risk of fluid/electrolyte disturbance

Creatinine, eGFR, urea, Na⁺, K⁺ and other relevant electrolytes

Guides fluid therapy, electrolyte correction and drug selection/dosing; renal dysfunction alters clearance of several anaesthetic drugs

LFT

Known/suspected liver disease, hepatitis, cirrhosis, jaundice, malnutrition, right heart failure with hepatic congestion, or relevant pregnancy-related disease such as HELLP

Hepatocellular injury and hepatic synthetic/nutritional status

Liver dysfunction may alter drug metabolism, protein binding and coagulation

Coagulation profile

Bleeding history, liver disease, anticoagulant therapy, severe pre-eclampsia, or when neuraxial/regional anaesthesia is being considered

PT/INR, aPTT, fibrinogen when indicated

Helps assess coagulation abnormalities and bleeding risk; particularly relevant before neuraxial procedures

12-lead ECG

Known/suspected CAD, previous MI, heart failure, hypertension, renal impairment, relevant symptoms, or selected patients with significant comorbidity/age

Rate, rhythm, conduction, ischaemic changes, LVH

Identifies arrhythmias, conduction abnormalities and evidence of cardiac disease that may alter perioperative management

Chest X-ray

Not routine. Consider when there is significant respiratory/cardiac disease, symptoms, or a specific surgical indication

Cardiomegaly, pulmonary pathology and other thoracic abnormalities

Helps assess significant cardiopulmonary pathology when clinically indicated

Pulmonary function tests

Known COPD/asthma when baseline assessment is useful; particularly relevant before lung resection or selected major thoracic surgery

FEV₁, FVC, DLCO

Assesses pulmonary reserve and helps determine suitability for lung resection; not routinely required in asymptomatic patients

ABG

Severe asthma/COPD undergoing major thoracic or abdominal surgery, significant respiratory disease, hypoxaemia/hypercapnia, or renal failure with tachypnoea

PaO₂, PaCO₂, pH, HCO₃⁻

Establishes baseline oxygenation, ventilation and acid–base status

Blood glucose

Known diabetes, suspected dysglycaemia, or patients receiving glucose-lowering therapy

Current glucose level

Allows perioperative glycaemic management and identification of significant hypo/hyperglycaemia

HbA1c

Known diabetes when recent glycaemic control is unavailable or when optimization is required

Longer-term glycaemic control

Helps assess adequacy of diabetic control and need for optimization

Blood grouping / Type & screen / Crossmatch

Surgery with significant anticipated blood loss, anaemia, major surgery or high transfusion risk

ABO/Rh group and compatible blood availability

Ensures blood/components can be made available when significant haemorrhage is anticipated

Pregnancy test

When pregnancy is possible and the result could alter anaesthetic, surgical, imaging or medication management

Pregnancy status

Pregnancy significantly alters airway, respiratory, cardiovascular and aspiration considerations

Echocardiography

Suspected/significant valvular disease, heart failure, unexplained dyspnoea or other clinical indication

Ventricular function, valves and cardiac structure

Helps assess cardiac reserve and guide perioperative haemodynamic planning

Urinalysis

Urinary symptoms, suspected UTI or selected procedures where the result will affect management

Urinary infection/proteinuria/other abnormalities

Identifies clinically relevant urinary pathology when indicated

VM (Viral Markers)

According to institutional policy, occupational-health requirements, relevant clinical history, suspected or known viral infection, or when the result will affect perioperative planning

Relevant viral infection markers, such as hepatitis B, hepatitis C and HIV, as clinically or institutionally indicated

Supports infection-control planning, appropriate precautions and perioperative management; a positive result should not delay urgent surgery

What is truly “routine”?

There is no universal routine investigation panel.

For a young, healthy, asymptomatic patient undergoing minor surgery, extensive laboratory and imaging investigations may not be required.

For a patient with significant comorbidities or major surgery, investigations become more extensive and should be targeted to the clinical problem.

Every investigation should have a reason. Ask: “If this result is abnormal, will it change my management?”


References

  1. Miller RD, Cohen NH, Eriksson LI, et al. Miller’s Anesthesia. Elsevier.
    — Perioperative evaluation, preoperative testing, and anesthetic risk assessment.
  2. Butterworth JF, Mackey DC, Wasnick JD. Morgan & Mikhail’s Clinical Anesthesiology. McGraw-Hill.
    — Preoperative evaluation and selection/interpretation of laboratory investigations.
  3. Barash PG, Cullen BF, Stoelting RK, et al. Clinical Anesthesia. Wolters Kluwer.
    — Preoperative assessment and perioperative laboratory testing.
  4. American Society of Anesthesiologists (ASA). Practice Advisory for Preanesthesia Evaluation.
    — Guidance on appropriate preanesthetic assessment and investigations.
  5. National Institute for Health and Care Excellence (NICE). Routine Preoperative Tests for Elective Surgery (NG45).
    — Evidence-based recommendations on when CBC, coagulation studies, renal function, ECG, chest X-ray and other investigations should be performed.

6.    Goneppanavar U et al. Preoperative Investigations: Practice             Guidelines from the Indian Society of Anaesthesiologists. Indian J Anaesth. 2022;66(5):319–343, Table 6, Recommendations 1–10.


Scroll to Top